These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 7858913

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice.
    Leppänen P, Luoma JS, Hofker MH, Havekes LM, Ylä-Herttuala S.
    Atherosclerosis; 1998 Jan; 136(1):147-52. PubMed ID: 9544741
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall.
    Shimano H, Ohsuga J, Shimada M, Namba Y, Gotoda T, Harada K, Katsuki M, Yazaki Y, Yamada N.
    J Clin Invest; 1995 Feb; 95(2):469-76. PubMed ID: 7860728
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endothelial-smooth muscle cell interactions during atherosclerosis.
    Hajjar DP, Salisbury BG.
    Pathol Immunopathol Res; 1986 Feb; 5(6):437-54. PubMed ID: 3039483
    [No Abstract] [Full Text] [Related]

  • 7. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis.
    Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P.
    Am J Pathol; 1992 Feb; 140(2):301-16. PubMed ID: 1739124
    [Abstract] [Full Text] [Related]

  • 8. Lipoprotein modification: cellular mechanisms.
    Chait A, Heinecke JW.
    Curr Opin Lipidol; 1994 Oct; 5(5):365-70. PubMed ID: 7858911
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development of the lipid-rich core in human atherosclerosis.
    Guyton JR, Klemp KF.
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):4-11. PubMed ID: 8548424
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice.
    Condorelli G, Aycock JK, Frati G, Napoli C.
    FASEB J; 2001 Oct; 15(12):2162-70. PubMed ID: 11641242
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.
    Bellosta S, Mahley RW, Sanan DA, Murata J, Newland DL, Taylor JM, Pitas RE.
    J Clin Invest; 1995 Nov; 96(5):2170-9. PubMed ID: 7593602
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice.
    Chyu KY, Babbidge SM, Zhao X, Dandillaya R, Rietveld AG, Yano J, Dimayuga P, Cercek B, Shah PK.
    Circulation; 2004 May 25; 109(20):2448-53. PubMed ID: 15136500
    [Abstract] [Full Text] [Related]

  • 20. Population dynamics of arterial cells during atherogenesis. XI. Slowdown in multiplication and death rates of lesion smooth muscle cells in swine during the period 105-165 days after balloon endothelial cell denudation followed by a hyperlipidemic diet.
    Thomas WA, Scott RF, Florentin RA, Reiner JM, Lee KT.
    Exp Mol Pathol; 1981 Oct 25; 35(2):153-62. PubMed ID: 7286156
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.